Business · 07/10/2014Updated: 10/17/2026 · 1 min read
FDA Announces Approval of User Fee Guidance for Drug and Biological Products
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to user fee waivers, reductions, and refunds for drug and biological products, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →